LXS196 for Metastatic Uveal Melanoma - Finally Some Progress

Overview

Journal Br J Cancer

Specialty Oncology

Date 2023 Mar 1

PMID 36859685

Authors

A Rodrigues

R Cosman

A M Joshua

Affiliations

Soon will be listed here.

Citing Articles

Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting.

Ventin M, Cattaneo G, Arya S, Jia J, Gelmi M, Sun Y Clin Cancer Res. 2024; 30(15):3243-3258.

PMID: 38767611 PMC: 11572477. DOI: 10.1158/1078-0432.CCR-24-0071.

High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma.

Arang N, Lubrano S, Ceribelli M, Rigiracciolo D, Saddawi-Konefka R, Faraji F Cell Rep Med. 2023; 4(11):101244.

PMID: 37858338 PMC: 10694608. DOI: 10.1016/j.xcrm.2023.101244.

Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond.

Gerard C, Shum B, Nathan P, Turajlic S Immunooncol Technol. 2023; 19:100386.

PMID: 37483658 PMC: 10362360. DOI: 10.1016/j.iotech.2023.100386.

References

Singh A, Kalyani P, Topham A . Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005; 112(10):1784-9. DOI: 10.1016/j.ophtha.2005.06.011. View

Djulbegovic M, Taylor D, Uversky V, Galor A, Shields C, Karp C . Intrinsic Disorder in BAP1 and Its Association with Uveal Melanoma. Genes (Basel). 2022; 13(10). PMC: 9601668. DOI: 10.3390/genes13101703. View

Harbour J, Onken M, Roberson E, Duan S, Cao L, Worley L . Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010; 330(6009):1410-3. PMC: 3087380. DOI: 10.1126/science.1194472. View

Khoja L, Atenafu E, Suciu S, Leyvraz S, Sato T, Marshall E . Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study. Ann Oncol. 2019; 30(8):1370-1380. DOI: 10.1093/annonc/mdz176. View

Algazi A, Tsai K, Shoushtari A, Munhoz R, Eroglu Z, Piulats J . Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies. Cancer. 2016; 122(21):3344-3353. PMC: 5767160. DOI: 10.1002/cncr.30258. View

Pelster M, Gruschkus S, Bassett R, Gombos D, Shephard M, Posada L . Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study. J Clin Oncol. 2020; 39(6):599-607. PMC: 8257877. DOI: 10.1200/JCO.20.00605. View

Piulats J, Espinosa E, de la Cruz Merino L, Varela M, Alonso Carrion L, Martin-Algarra S . Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402). J Clin Oncol. 2021; 39(6):586-598. DOI: 10.1200/JCO.20.00550. View

Nathan P, Hassel J, Rutkowski P, Baurain J, Butler M, Schlaak M . Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med. 2021; 385(13):1196-1206. DOI: 10.1056/NEJMoa2103485. View

Van Raamsdonk C, Griewank K, Crosby M, Garrido M, Vemula S, Wiesner T . Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010; 363(23):2191-9. PMC: 3107972. DOI: 10.1056/NEJMoa1000584. View

10.

NISHIZUKA Y . Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995; 9(7):484-96. View

11.

Chen X, Wu Q, Depeille P, Chen P, Thornton S, Kalirai H . RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma. Cancer Cell. 2017; 31(5):685-696.e6. PMC: 5499527. DOI: 10.1016/j.ccell.2017.04.002. View

12.

Shoushtari A, Khan S, Komatsubara K, Feun L, Acquavella N, Singh-Kandah S . A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers (Basel). 2021; 13(21). PMC: 8583628. DOI: 10.3390/cancers13215504. View

13.

Park J, Stewart A, Irvine M, Pedersen B, Ming Z, Carlino M . Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling. Cancer Gene Ther. 2022; 29(10):1384-1393. PMC: 9576594. DOI: 10.1038/s41417-022-00457-2. View

14.

Tanaka R, Mizue Terai , Londin E, Sato T . The Role of HGF/MET Signaling in Metastatic Uveal Melanoma. Cancers (Basel). 2021; 13(21). PMC: 8582360. DOI: 10.3390/cancers13215457. View